Bioxytran, Inc (BIXT) stock
BIXTOTCPharmaceutical PreparationsFiscal year ends December 31
$0.02−0.00 (-3.95%)
Close on Oct 19, 2026Market cap $2.56MP/E –Yield –
Bioxytran price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Bioxytran's price to sales ratio was 304.4× on Oct 31, 2018, against 51.7× a year earlier. Over the last 3 years it ranged from 28.9× to 467.7×, with a median of 139.1×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2018 | Oct 31, 2018 | 304.4× | −33.4 |
| 2017 | Dec 29, 2017 | 337.8× | +260.8 |
| 2016 | Dec 30, 2016 | 76.9× | −83.1 |
| 2015 | Jan 30, 2015 | 160.0× | +0.0 |
| 2014 | Dec 31, 2014 | 160.0× | −303.9 |
| 2013 | Apr 30, 2013 | 464.0× | – |
See a number that looks wrong?